Clinical Trials Directory

Trials / Conditions / Hereditary Breast/Ovarian Cancer (brca1, brca2)

Hereditary Breast/Ovarian Cancer (brca1, brca2)

9 registered clinical trials studyying Hereditary Breast/Ovarian Cancer (brca1, brca2) — 3 currently recruiting.

StatusTrialSponsorPhase
Not Yet RecruitingEvaluation of Well Being and Patient Reported Outcomes After Robotic Single-port Nipple Sparing Mastectomy and
NCT07236359
Beaumont HospitalN/A
Enrolling By InvitationPatient Centered Clinical Decision Support for Hereditary Cancer Syndromes
NCT06914726
HealthPartners InstituteN/A
CompletedGenetics and Heart Health After Cancer Therapy
NCT03510689
Abramson Cancer Center at Penn Medicine—
UnknownOutcomes After Perforator Flap Reconstruction for Breast Reconstruction and/or Lymphedema Treatment
NCT01273909
The National Institute of Lymphology—
CompletedLetrozole in Preventing Breast Cancer in Postmenopausal Women With a BRCA1 or BRCA2 Mutation
NCT00673335
UNICANCERPhase 3
CompletedStandard Genetic Counseling With or Without a Decision Guide in Improving Communication Between Mothers Underg
NCT00685256
Georgetown UniversityPhase 3
CompletedCarboplatin or Docetaxel in Treating Women With Metastatic Genetic Breast Cancer
NCT00321633
University College London HospitalsPhase 2
CompletedArzoxifene or Tamoxifen in Preventing Breast Cancer in Premenopausal Women at High Risk for Breast Cancer
NCT00253539
The Cleveland ClinicPhase 2
RecruitingSpecimen and Data Study for Ovarian Cancer Early Detection and Prevention
NCT00005095
Northwestern University—